T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens
Marginal zone (MZ) B cells are one of the main actors of T-independent (TI) responses in mice. To identify the B cell subset(s) involved in such responses in humans, we vaccinated healthy individuals with Pneumovax, a model TI vaccine. By high-throughput repertoire sequencing of plasma cells (PCs) isolated 7 days after vaccination and of different B cell subpopulations before and after vaccination, we show that the PC response mobilizes large clones systematically, including an immunoglobulin M component, whose diversification and amplification predated the pneumococcal vaccination. These clones could be mainly traced back to MZ B cells, together with clonally related IgA+ and, to a lesser extent, IgG+CD27+ B cells. Recombinant monoclonal antibodies isolated from large PC clones recognized a wide array of bacterial species from the gut flora, indicating that TI responses in humans largely mobilize MZ and switched B cells that most likely prediversified during mucosal immune responses against bacterial antigens and acquired pneumococcal cross-reactivity through somatic hypermutation.
Errataetall: |
CommentIn: Immunol Lett. 2023 Apr-May;256-257:66-67. - PMID 37040847 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Science immunology - 8(2023), 79 vom: 27. Jan., Seite eade1413 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Weller, Sandra [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antigens, Bacterial |
---|
Anmerkungen: |
Date Completed 03.02.2023 Date Revised 03.10.2023 published: Print-Electronic CommentIn: Immunol Lett. 2023 Apr-May;256-257:66-67. - PMID 37040847 Citation Status MEDLINE |
---|
doi: |
10.1126/sciimmunol.ade1413 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352166363 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352166363 | ||
003 | DE-627 | ||
005 | 20231226053108.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1126/sciimmunol.ade1413 |2 doi | |
028 | 5 | 2 | |a pubmed24n1173.xml |
035 | |a (DE-627)NLM352166363 | ||
035 | |a (NLM)36706172 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Weller, Sandra |e verfasserin |4 aut | |
245 | 1 | 0 | |a T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.02.2023 | ||
500 | |a Date Revised 03.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Immunol Lett. 2023 Apr-May;256-257:66-67. - PMID 37040847 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Marginal zone (MZ) B cells are one of the main actors of T-independent (TI) responses in mice. To identify the B cell subset(s) involved in such responses in humans, we vaccinated healthy individuals with Pneumovax, a model TI vaccine. By high-throughput repertoire sequencing of plasma cells (PCs) isolated 7 days after vaccination and of different B cell subpopulations before and after vaccination, we show that the PC response mobilizes large clones systematically, including an immunoglobulin M component, whose diversification and amplification predated the pneumococcal vaccination. These clones could be mainly traced back to MZ B cells, together with clonally related IgA+ and, to a lesser extent, IgG+CD27+ B cells. Recombinant monoclonal antibodies isolated from large PC clones recognized a wide array of bacterial species from the gut flora, indicating that TI responses in humans largely mobilize MZ and switched B cells that most likely prediversified during mucosal immune responses against bacterial antigens and acquired pneumococcal cross-reactivity through somatic hypermutation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antigens, Bacterial |2 NLM | |
650 | 7 | |a Pneumococcal Vaccines |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
700 | 1 | |a Sterlin, Delphine |e verfasserin |4 aut | |
700 | 1 | |a Fadeev, Tatiana |e verfasserin |4 aut | |
700 | 1 | |a Coignard, Eva |e verfasserin |4 aut | |
700 | 1 | |a Verge de Los Aires, Alba |e verfasserin |4 aut | |
700 | 1 | |a Goetz, Clara |e verfasserin |4 aut | |
700 | 1 | |a Fritzen, Rémi |e verfasserin |4 aut | |
700 | 1 | |a Bahuaud, Mathilde |e verfasserin |4 aut | |
700 | 1 | |a Batteux, Frederic |e verfasserin |4 aut | |
700 | 1 | |a Gorochov, Guy |e verfasserin |4 aut | |
700 | 1 | |a Weill, Jean-Claude |e verfasserin |4 aut | |
700 | 1 | |a Reynaud, Claude-Agnès |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Science immunology |d 2016 |g 8(2023), 79 vom: 27. Jan., Seite eade1413 |w (DE-627)NLM263875547 |x 2470-9468 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2023 |g number:79 |g day:27 |g month:01 |g pages:eade1413 |
856 | 4 | 0 | |u http://dx.doi.org/10.1126/sciimmunol.ade1413 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2023 |e 79 |b 27 |c 01 |h eade1413 |